Sagittarius Life Science Corp

TPEX:3205 Stock Report

Market Cap: NT$1.3b

Sagittarius Life Science Balance Sheet Health

Financial Health criteria checks 6/6

Sagittarius Life Science has a total shareholder equity of NT$526.9M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$664.7M and NT$137.8M respectively.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ration/a
CashNT$215.38m
EquityNT$526.90m
Total liabilitiesNT$137.82m
Total assetsNT$664.72m

Recent financial health updates

Recent updates

We Think Sagittarius Life Science (GTSM:3205) Can Afford To Drive Business Growth

Apr 11
We Think Sagittarius Life Science (GTSM:3205) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Sagittarius Life Science's (GTSM:3205) Cash Burn Situation

Dec 27
Here's Why We're Not Too Worried About Sagittarius Life Science's (GTSM:3205) Cash Burn Situation

Financial Position Analysis

Short Term Liabilities: 3205's short term assets (NT$332.9M) exceed its short term liabilities (NT$127.1M).

Long Term Liabilities: 3205's short term assets (NT$332.9M) exceed its long term liabilities (NT$10.7M).


Debt to Equity History and Analysis

Debt Level: 3205 is debt free.

Reducing Debt: 3205 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 3205 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 3205 has sufficient cash runway for 2.4 years if free cash flow continues to grow at historical rates of 3.6% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.